See more : Tips Industries Limited (TIPSINDLTD.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Sofiva Genomics Co.,Ltd. (6615.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sofiva Genomics Co.,Ltd., a leading company in the None industry within the None sector.
You may be interested
- PharmaResearch Co., Ltd. (214450.KQ) Income Statement Analysis – Financial Results
- NuEnergy Gas Limited (NGY.AX) Income Statement Analysis – Financial Results
- Yantai North Andre Juice Co.,Ltd. (605198.SS) Income Statement Analysis – Financial Results
- Dr. Reddy’s Laboratories Limited (DRREDDY.BO) Income Statement Analysis – Financial Results
- Canon Marketing Japan Inc. (8060.T) Income Statement Analysis – Financial Results
Sofiva Genomics Co.,Ltd. (6615.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 466.80M | 495.78M | 508.42M | 488.87M | 509.45M |
| Cost of Revenue | 336.89M | 346.79M | 331.60M | 336.12M | 311.46M |
| Gross Profit | 129.91M | 148.99M | 176.81M | 152.74M | 197.98M |
| Gross Profit Ratio | 27.83% | 30.05% | 34.78% | 31.24% | 38.86% |
| Research & Development | 9.64M | 10.34M | 10.80M | 9.62M | 7.94M |
| General & Administrative | 83.08M | 82.99M | 79.50M | 69.75M | 0.00 |
| Selling & Marketing | 53.07M | 52.36M | 51.42M | 52.80M | 0.00 |
| SG&A | 136.15M | 135.35M | 130.91M | 122.54M | 123.32M |
| Other Expenses | 0.00 | 2.48M | -1.20M | 413.00K | 0.00 |
| Operating Expenses | 145.79M | 145.69M | 141.71M | 132.17M | 131.26M |
| Cost & Expenses | 482.68M | 492.47M | 473.31M | 468.29M | 442.72M |
| Interest Income | 1.46M | 672.00K | 346.00K | 411.00K | 510.00K |
| Interest Expense | 1.29M | 1.49M | 1.74M | 1.97M | 1.97M |
| Depreciation & Amortization | 41.34M | 42.79M | 41.95M | 48.17M | 40.84M |
| EBITDA | 27.86M | 91.14M | 107.25M | 87.06M | 108.63M |
| EBITDA Ratio | 5.97% | 18.38% | 21.09% | 17.81% | 21.32% |
| Operating Income | -15.88M | 48.35M | 65.29M | 38.90M | 66.72M |
| Operating Income Ratio | -3.40% | 9.75% | 12.84% | 7.96% | 13.10% |
| Total Other Income/Expenses | 24.79M | -1.00M | -1.60M | -1.62M | -903.00K |
| Income Before Tax | 8.90M | 47.35M | 63.69M | 37.28M | 65.82M |
| Income Before Tax Ratio | 1.91% | 9.55% | 12.53% | 7.63% | 12.92% |
| Income Tax Expense | -3.02M | 4.20M | 6.92M | 3.07M | 12.94M |
| Net Income | 11.53M | 42.78M | 56.98M | 34.62M | 62.67M |
| Net Income Ratio | 2.47% | 8.63% | 11.21% | 7.08% | 12.30% |
| EPS | 0.54 | 2.00 | 2.68 | 1.63 | 2.96 |
| EPS Diluted | 0.54 | 2.00 | 2.68 | 1.62 | 2.92 |
| Weighted Avg Shares Out | 21.36M | 21.36M | 21.28M | 21.23M | 21.17M |
| Weighted Avg Shares Out (Dil) | 21.37M | 21.38M | 21.29M | 21.38M | 21.46M |
No news found for: 6615.TWO
Source: https://incomestatements.info
Category: Stock Reports